EEX Group increased trading volumes across the majority of its markets in the first half of 2019, with volumes up significantly in the power, gas and freight markets. Trading volumes in the Agricultural market also developed positively while the Group
Man Group has reported a 5 per cent increase in funds under management (FUM)1 to USD114.4 billion in the first six months of 2019 up from USD108.5 billion as at 31 December 2018 on the back of strong performance by
Gemini experienced record-breaking growth in 2017, with an 80 per cent increase in the number of registered fund launches executed during the year. When surveyed, clients cited the key drivers in selecting Gemini for their new funds, including: • Gemini’s
AlphaDesk, a cloud-based Order Management and Portfolio Management System provider to hedge funds and other investment managers, posted record new business sales for the first half of 2017. Kevin Galliers, COO, says: “We signed 36 new hedge funds during the
SS&C Technologies Holdings has signed on more than 150 clients to Eze Eclipse, SS&C Eze’s cloud-based front-to-back office investment management platform.
Blue Sky Alternative Investments has reported a significant rise in revenue, profitability, cash flow, margins and fee-earning assets under management for the half-year period ending 31 December 2016, driven by growth in alternative assets. Underlying net profit after tax (NPAT)
CME Group has declared a first-quarter dividend of USD0.66 per share, a 10 per cent increase from the prior rate of USD0.60 per share. The dividend is payable on 27 March 2017 to shareholders of record as of 10 March 2017.
CME Group has reported revenue of USD913 million and operating income of USD540 million for the fourth quarter of 2016. Net income was USD373 million and diluted earnings per share were USD1.10. On an adjusted basis, net income was
Euronext has published its first Biotech Barometer, a quarterly tool that offers an insight into major trends in biotechnology companies, which includes only companies offering diagnostics and therapies listed on Euronext markets. Designed in partnership with Biotech Bourse, the barometer
Nasdaq has reported record fourth quarter 2016 net revenues of USD599 million, up USD63 million or 12 per cent from USD536 million in the prior year period, driven primarily by a USD54 million positive impact from acquisitions. Organic growth in
